Record Details

Prospects and Trends in the Brazilian Market for Biologically Sourced Products

Journal of Technology Management & Innovation

View Archive Info
 
 
Field Value
 
Title Prospects and Trends in the Brazilian Market for Biologically Sourced Products
 
Creator Madeira, Luciana da Silva
Borschiver, Suzana
Pereira Jr, Nei
 
Subject production, biopharmaceuticals, specialty drugs, strategic medication, patents, technological forecasting
 
Description The aim of this paper was to select the most interesting Brazilian biopharmaceuticals, with the best market opportunity for production. The biopharmaceuticals filgrastim, infliximab, somatropin, imiglucerase, betainterferon and factor VIII were selected because they are not produced in Brazil and thus could increase the technological capacity of domestic production. The use of a data mining tool facilitated the results achieved here, using the patents deposited in several banks worldwide as the source information. The prospects and trends of producing biopharmaceuticals in Brazil are of great interest to the country to establish a competitive industry and reduce the vulnerability of the National Health System, such as display windows of opportunity, showing the possibility of moving towards the production of biopharmaceuticals.
 
Publisher Facultad de Economía y Negocios, Universidad Alberto Hurtado
 
Contributor —
 
Date 2012-09-19
 
Type info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Artículo revisado por pares
 
Format application/pdf
 
Identifier http://www.jotmi.org/index.php/GT/article/view/art265
10.4067/S0718-27242012000300005
 
Source Journal of Technology Management & Innovation; Vol 7, No 3 (2012); 44-56
Journal of Technology Management & Innovation; Vol 7, No 3 (2012); 44-56
0718-2724
 
Language eng
 
Relation http://www.jotmi.org/index.php/GT/article/view/art265/705
 
Rights Copyright (c) 2012 Journal of Technology Management & Innovation
http://creativecommons.org/licenses/by/4.0